Recent advancements in the cardiovascular drug carriers

References

• Alwan A. 2011. Global Status Report on Noncommunicable Diseases 2010. Geneva: World Health Organization.
   Google Scholar
• Anthea M, Hopkins J, Mclaughlin CW, Johnson S, Warner MQ, Lahart D, Wright JD. 1993. Human Biology and Health. Englewood Cliffs: New Jersey, pp 76–134.
   Google Scholar
• Arora N, Bilandi A, Garg T. 2012a. Microneedle: as a future prospective tool. Int Res J Pharm. 3:102–105.
   Google Scholar
• Arora N, Singh K, Garg T. 2012b. Areas of nanomedicine applications. Int J Univ Pharm Life Sci. 2:216–227.
   Google Scholar
• Chang T. 2011. Nanobiotechnology-based blood substitutes and the cardiovascular systems in transfusion medicine. Nanomedicine Cardiovasc Syst. 77–98.
   Google Scholar
• Chang TM. 2012. From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond. Artif Cells Blood Substit Immobil Biotechnol. 40:197–199.
   PubMed Web of Science ®Google Scholar
• Christian DA, Cai S, Bowen DM, Kim Y, Pajerowski JD, Discher DE. 2009. Polymersome carriers: from self-assembly to siRNA and protein therapeutics. Eur J Pharm Biopharm. 71:463–474.
   PubMed Web of Science ®Google Scholar
• Dantas AP, Jiménez-Altayó F, Vila E. 2012. Vascular aging: facts and factors. Front Physiol. 3:325.
   PubMed Web of Science ®Google Scholar
• Ding B-S, Dziubla T, Shuvaev VV, Muro S, Muzykantov VR. 2006. Advanced drug delivery systems that target the vascular endothelium. Mol Interv. 6:98.
   PubMed Web of Science ®Google Scholar
• Discher BM, Won Y-Y, Ege DS, Lee JC, Bates FS, Discher DE, Hammer DA. 1999. Polymersomes: tough vesicles made from diblock copolymers. Science. 284:1143–1146.
   PubMed Web of Science ®Google Scholar
• Fuster V, Kelly BB. 2010 Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health Washington, DC: National Academies Press.
   Google Scholar
• Gagandeep GARG, T., Malik B, Rath G, Goyal AK. 2014. Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur J Pharm Sci. 53:10–16.
   PubMed Web of Science ®Google Scholar
• Garg T. 2012. An evolutionary approaches in development of needle free injection technologies. Int J Pharm Pharm Sci. 4:590–596.
   Google Scholar
• Garg T. 2014. Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol. 1–8.
   Google Scholar
• Garg T, Bilandi A, Kapoor B. 2011a. Scaffold: tissue engineering and regenerative medicine. Int Res J Pharm. 2:37–42.
   Google Scholar
• Garg T, Bilandi A, Kapoor B. 2012a. Evolutionary approaches for drug and gene delivery by micro and nano magnetic carriers. Indo-global Res J Pharm Sci. 2:182–189.
   Google Scholar
• Garg T, Chanana A, Sharma G. 2012b. Pulsatile drug delivery systems: pulsincap system. IOSR J Pharm. 2:338–339.
   Google Scholar
• Garg T, Goyal AK. 2012. Iontophoresis: drug delivery system by applying an electrical potential across the skin. Drug Deliv Lett. 2:270–280.
   Google Scholar
• Garg T, Goyal AK. 2014a. Biomaterial-based scaffolds–current status and future directions. Expert Opin Drug Deliv. 11:767–789.
   PubMed Web of Science ®Google Scholar
• Garg T, Goyal AK. 2014b. Liposomes: targeted and controlled delivery system. Drug Deliv Lett. 4:62–71.
   Google Scholar
• Garg T, Goyal AK, Arora S, Murthy R. 2012c. Development, optimization and evaluation of porous chitosan scaffold formulation of gliclazide for the treatment of Type-2 diabetes mellitus. Drug Deliv Lett. 2:251–261.
   Google Scholar
• Garg T, Rath G, Goyal AK. 2014. Comprehensive review on additives of topical dosage forms for drug delivery. Drug Deliv.
   Google Scholar
• Garg T, Singh O, Arora S, Murthy R. 2011b. Dendrimer—A novel scaffold for drug delivery. Int J Pharm Sci Rev Res. 7:211–220.
   Google Scholar
• Garg T, Singh O, Arora S, Murthy R. 2012d. Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst. 29:1–63.
   PubMed Web of Science ®Google Scholar
• Garg T, Singh S, Goyal AK. 2013. Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst. 30:369–409.
   PubMed Web of Science ®Google Scholar
• Geiser M, Rothen-Rutishauser B, Kapp N, Schürch S, Kreyling W, Schulz H, et al. 2005. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect. 113:1555.
   PubMed Web of Science ®Google Scholar
• Goyal AK, Rath G, Garg T. 2013a. Nanotechnological approaches for genetic immunization. In: Erdmann VA and Barciszewski J, Eds. DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases Berlin: Springer, pp. 67–120.
   Google Scholar
• Goyal G, Garg T, Malik B, Chauhan G, Rath G, Goyal AK. 2013b. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv.
   Google Scholar
• Gundogdu E, Senyigit Z, Ilem-Ozdemir D. 2014. Nanomedicine for the diagnosis and treatment of cardiovascular disease: current status and future perspective. Cardiovascr Dis I.
   Google Scholar
• Haeri A, Sadeghian S, Rabbani S, Anvari MS, Boroumand MA, Dadashzadeh S. 2011. Use of remote film loading methodology to entrap sirolimus into liposomes: Preparation, characterization and in vivo efficacy for treatment of restenosis. Int J Pharm. 414:16–27.
   PubMed Web of Science ®Google Scholar
• Huang CC, Liao ZX, Chen DY, Hsiao CW, Chang Y, Sung HW. 2014. Injectable cell constructs fabricated via culture on a thermoresponsive methylcellulose hydrogel system for the treatment of ischemic diseases. Adv Healthc Mater.
   Web of Science ®Google Scholar
• Ise M, Ise H, Shiba Y, Kobayashi S, Goto M, Takahashi M, et al. 2011. Targeting N-acetylglucosamine-bearing polymer-coated liposomes to vascular smooth muscle cells. J Artif Organs. 14:301–309.
   PubMed Web of Science ®Google Scholar
• Jagdale SC, Sali MS, Barhate AL, Kuchekar BS, Chabukswar AR. 2013. Formulation, development, and evaluation of floating pulsatile drug delivery system of atenolol. PDA J Pharm Sci Technol. 67:214–228.
   PubMedGoogle Scholar
• Janib SM, Moses AS, Mackay JA. 2010. Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev. 62:1052–1063.
   PubMed Web of Science ®Google Scholar
• Jeon G, Yang SY, Byun J, Kim JK. 2011. Electrically actuatable smart nanoporous membrane for pulsatile drug release. Nano Lett. 11:1284–1288.
   PubMed Web of Science ®Google Scholar
• Jordan SW, Chaikof EL. 2007. Novel thromboresistant materials. J Vasc Surg. 45:A104–A115.
   PubMed Web of Science ®Google Scholar
• Jung H, Jang M-K, Nah J-W, Kim Y-B. 2009. Synthesis and characterization of thermosensitive nanoparticles based on PNIPAAm core and chitosan shell structure. Macromol Res. 17:265–270.
   Web of Science ®Google Scholar
• Karavas E, Georgarakis E, Bikiaris D. 2006. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur J Pharm Biopharm. 64:115–126.
   PubMed Web of Science ®Google Scholar
• Kataria K, Sharma A, Garg T, Goyal AK, Rath G. 2014. Novel technology to improve drug loading in polymeric nanofibers. Drug Deliv Lett. 4:79–86.
   Google Scholar
• Kaur M, Garg T, Rath G, Goyal AK. 2014a. Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst. 31:49–88.
   PubMed Web of Science ®Google Scholar
• Kaur M, Malik B, Garg T, Rath G, Goyal AK. 2014b. Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv.
   PubMed Web of Science ®Google Scholar
• Kona S, Dong J-F, Liu Y, Tan J, Nguyen KT. 2012. Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery system. Int J Pharm. 423:516–524.
   PubMed Web of Science ®Google Scholar
• Lee CC, Mackay JA, Fréchet JM, Szoka FC. 2005. Designing dendrimers for biological applications. Nat Biotechnol. 23: 1517–1526.
   PubMed Web of Science ®Google Scholar
• Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. 2013. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 380: 2224–2260.
   Web of Science ®Google Scholar
• Liu Y, Liu S, Dai Q. 2009. Design and evaluation of pH-independent pulsatile release pellets containing isosorbide-5-mononitrate. Chem Pharm Bull. 57:55–60.
   PubMed Web of Science ®Google Scholar
• Magrez A, Kasas S, Salicio V, Pasquier N, Seo JW, Celio M, et al. 2006. Cellular toxicity of carbon-based nanomaterials. Nano Lett. 6:1121–1125.
   PubMed Web of Science ®Google Scholar
• Mathers C, Fat DM, Boerma J. 2008. The Global Burden of Disease: 2004 Update. Geneva: World Health Organization.
   Google Scholar
• Mathers CD, Loncar D. 2006. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3:e442.
   PubMed Web of Science ®Google Scholar
• McGill HC, Mcmahan CA, Gidding SS. 2008. Preventing Heart Disease in the 21st Century Implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study. Circulation. 117:1216–1227.
   PubMed Web of Science ®Google Scholar
• Miyake F, Kamogawa A, Sakakibara M. 1998. [Drug delivery system in cardiovascular drugs]. Nihon Rinsho. 56:737–741.
   PubMedGoogle Scholar
• Mobed M, Chang TM. 1998. Comparison of polymerically stabilized PEG-grafted liposomes and physically adsorbed carboxymethylchitin and carboxymethyl/glycolchitin liposomes for biological applications. Biomaterials. 19:1167–1177.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. 2005. Nanomedicine: current status and future prospects. FASEB J. 19:311–330.
   PubMed Web of Science ®Google Scholar
• Nel A, Xia T, Mädler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science. 311:622–627.
   PubMed Web of Science ®Google Scholar
• Nishiya T, Chang TM. 1994. Toxicity of liposomes containing low mol% of dienoyl phosphocholine to blood: use of carboxymethyl chitin to reduce toxicity. Artif Cells Blood Substit Immobil Biotechnol. 22:883–888.
   PubMed Web of Science ®Google Scholar
• Parnami N, Garg T, Rath G, Goyal AK. 2013. Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotechnol.
   PubMed Web of Science ®Google Scholar
• Patel SS. 2006. Liposome: a versatile platform for targeted delivery of drugs. Pharmainfonet. 5:1–5.
   Google Scholar
• Photos PJ, Bacakova L, Discher B, Bates FS, Discher DE. 2003. Polymer vesicles in vivo: correlations with PEG molecular weight. J Control Release. 90:323–334.
   PubMed Web of Science ®Google Scholar
• Pi F, Tu X, Wu Y. 2010. [Preparation of ATP-2Na loaded liposome and its effect on tissues energy state in myocardial ischemic mice]. Yao Xue Xue Ba.o, 45:1322–1326.
   PubMedGoogle Scholar
• Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, et al. 1998. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med. 339:861–867.
   PubMed Web of Science ®Google Scholar
• Sharma G, Garg T. 2012. Importance and application of gene therapy. Int J Institut Pharm Life Sci. 2:205–220.
   Google Scholar
• Shuvaev VV, Dziubla T, Wiewrodt R, Muzykantov VR. 2004. Streptavidin-biotin crosslinking of therapeutic enzymes with carrier antibodies. In: Niemeyer CM, Ed. Bioconjugation Protocols. Berlin: Springer.
   Google Scholar
• Singh H, Sharma R, Joshi M, Garg T, Goyal AK, Rath G. 2014a. Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol.
   Web of Science ®Google Scholar
• Singh K, Arora N, Garg T. 2012a. RFID: A trustable security tool in pharmaceutical industry. Am J Pharm Tech Res. 2:113–127.
   Google Scholar
• Singh K, Arora N, Garg T. 2012b. Superbug: antimicrobial resistance due to NDM-1. Int J Institut Pharm Life Sci. 2:58–66.
   Google Scholar
• Singh O, Garg T, Rath G, Goyal AK. 2014b. Microbicides for the treatment of sexually transmitted HIV infections. J Pharm. 1–18.
   Google Scholar
• Song C, Labhasetwar V, Cui X, Underwood T, Levy RJ. 1998. Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model. J Control Release. 54: 201–211.
   PubMed Web of Science ®Google Scholar
• Sutton JT, Haworth KJ, Pyne-Geithman G, Holland CK. 2013. Ultrasound-mediated drug delivery for cardiovascular disease. Expert Opin Drug Deliv. 10:573–592.
   PubMed Web of Science ®Google Scholar
• Takahama H, Shigematsu H, Asai T, Matsuzaki T, Sanada S, Fu HY, et al. 2013. Liposomal amiodarone augments anti-arrhythmic effects and reduces hemodynamic adverse effects in an ischemia/reperfusion rat model. Cardiovasc Drugs Ther. 27:125–132.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. 2012. Multifunctional nanocarriers. Adv Drug Deliv Rev. 64:302–315.
   Web of Science ®Google Scholar
• Wang Y, Chang TM. 2012. Nanobiotechnological nanocapsules containing polyhemoglobin-tyrosinase: effects on murine B16F10 melanoma cell proliferation and attachment. J Skin Cancer. 2012:673291.
   PubMedGoogle Scholar
• Wiewrodt R, Thomas AP, Cipelletti L, Christofidou-Solomidou M, Weitz DA, Feinstein SI, et al. 2002. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. Blood. 99:912–922.
   PubMed Web of Science ®Google Scholar
• Wilson JT, Cui W, Sun X-L, Tucker-Burden C, Weber CJ, Chaikof EL. 2007. In vivo biocompatibility and stability of a substrate-supported polymerizable membrane-mimetic film. Biomaterials. 28:609–617.
   PubMed Web of Science ®Google Scholar